| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316855 | Clinical Biochemistry | 2018 | 22 Pages |
Abstract
A panel of three tumor markers CYFRA 21.1, HE4 and ProGRP may play a role for discriminating LC from benign lung disease and subtyping as SCLC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Elif Tugce Korkmaz, Deniz Koksal, Funda Aksu, Z.Gunnur Dikmen, Duygu Icen, Emin Maden, Sevgen Onder, Filiz Akbiyik, Salih Emri,